F Zhao, K Hang,
Q Zhou, L Shao, H Li… - Proceedings of the …, 2023 - National Acad Sciences
Glucose-dependent insulinotropic polypeptide receptor (GIPR) is a potential drug target for
metabolic disorders. It works with glucagon-like peptide-1 receptor and glucagon receptor in …